Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Inventory (2020 - 2025)

Rapid Micro Biosystems' Inventory history spans 6 years, with the latest figure at $21.1 million for Q3 2025.

  • For Q3 2025, Inventory fell 0.87% year-over-year to $21.1 million; the TTM value through Sep 2025 reached $21.1 million, down 0.87%, while the annual FY2024 figure was $20.2 million, 1.2% up from the prior year.
  • Inventory for Q3 2025 was $21.1 million at Rapid Micro Biosystems, up from $20.6 million in the prior quarter.
  • Across five years, Inventory topped out at $21.4 million in Q2 2024 and bottomed at $11.9 million in Q2 2021.
  • The 5-year median for Inventory is $20.6 million (2025), against an average of $19.5 million.
  • The largest annual shift saw Inventory surged 78.78% in 2022 before it fell 5.79% in 2023.
  • A 5-year view of Inventory shows it stood at $15.7 million in 2021, then surged by 35.2% to $21.2 million in 2022, then decreased by 5.79% to $20.0 million in 2023, then grew by 1.2% to $20.2 million in 2024, then increased by 4.3% to $21.1 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Inventory are $21.1 million (Q3 2025), $20.6 million (Q2 2025), and $20.7 million (Q1 2025).